SMC Pharma Services News and Resources

SMC Pharma Services has entered into a development agreement with a commercial-stage biopharmaceutical company focused on therapies for genetic rare diseases. This collaboration aims to develop an autoinjector platform solution for clinical trials scheduled for 2026. The partnership will utilise